Rheumatic diseases involve chronic inflammation and autoimmune responses that often affect the musculoskeletal system.\u201cOur review underscores the need for better-designed randomized trials to clarify who may benefit most,\u201d says Osvaldo Messina, co-chair of the Osteology Working Group and professor at the IRO Clinical Research and Regenerative Medicine Center in Argentina.\u00a0<\/p>\n
\u201cThere is a need for future large-scale studies that can stratify patients according to baseline vitamin D deficiency and genetic background to better understand the causal mechanisms and the long-term effect of vitamin D repletion in inflammatory rheumatic diseases.\u201d<\/p>\n
Meanwhile, a recent study revealed the importance of genes, supplementation, and disease, finding that vitamin D may help delay or prevent the progression of prediabetes, but only in people with certain genetic variations.<\/a><\/p>\n Importance of vitamin D<\/p>\n The researchers advise that maintaining serum 25-hydroxyvitamin D concentrations of at least 30 ng\/mL is needed for skeletal health. The recommendation aligns with the International Osteoporosis Foundation and other international bodies.<\/p>\n \u201cVitamin D remains an important component of comprehensive care for patients with inflammatory rheumatic diseases, particularly for bone and muscle health,\u201d comments corresponding author professor Patricia Clark, Faculty of Medicine, National Autonomous University of Mexico.\u00a0<\/p>\n \u201cHowever, despite promising biological mechanisms and observational associations, the current evidence indicates that vitamin D supplementation should not be viewed as a stand-alone disease-modifying therapy.\u201d<\/p>\n They also suggest future studies find optimal serum vitamin D thresholds for immune modulation alongside the long-term effects and safety of higher-dose supplementation strategies.<\/p>\n Vitamin D in headlines<\/p>\n A previous review supported that personalized exercise programs, improved nutrition, and vitamin D supplements are an effective trifecta approach to\u00a0prevent falls in aged care homes<\/a>.\u00a0<\/p>\nThe review urges better-designed randomized trials to clarify who may benefit most from vitamin D.To help better understand the role of this vitamin and immunological benefits, the research team outlines unresolved questions. It is not known whether vitamin D deficiency contributes directly to disease mechanisms or only reflects chronic inflammation.<\/p>\n